Stifel Financial Corp Veracyte, Inc. Transaction History

Stifel Financial Corp

$86.8 Billion
Q2 2024

A detailed history of Stifel Financial Corp transactions in Veracyte, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 32,512 shares of VCYT stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,512

Previous 30,949 5.05%

Holding current value

$1.1 Million

Previous $685,000 2.77%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$18.86 - $23.55 $29,478 - $36,808	1,563 Added 5.05%	32,512 $704,000
Q1 2024 May 13, 2024	BUY	$21.0 - $29.1 $73,311 - $101,588	3,491 Added 12.71%	30,949 $685,000
Q4 2023 Feb 12, 2024	BUY	$19.72 - $28.68 $47,170 - $68,602	2,392 Added 9.54%	27,458 $755,000
Q3 2023 Nov 13, 2023	BUY	$22.33 - $29.92 $848 - $1,136	38 Added 0.15%	25,066 $559,000
Q2 2023 Aug 14, 2023	BUY	$20.96 - $26.99 $2,431 - $3,130	116 Added 0.47%	25,028 $637,000
Q1 2023 May 12, 2023	SELL	$20.58 - $27.89 $493 - $669	-24 Reduced 0.1%	24,912 $555,000
Q4 2022 Feb 13, 2023	SELL	$15.31 - $29.94 $134,590 - $263,202	-8,791 Reduced 26.07%	24,936 $591,000
Q3 2022 Nov 14, 2022	SELL	$16.58 - $27.9 $5,819 - $9,792	-351 Reduced 1.03%	33,727 $560,000
Q2 2022 Aug 15, 2022	BUY	$15.45 - $29.52 $108,536 - $207,378	7,025 Added 25.97%	34,078 $678,000
Q1 2022 May 13, 2022	BUY	$21.94 - $42.51 $50,330 - $97,517	2,294 Added 9.27%	27,053 $746,000
Q4 2021 Feb 14, 2022	BUY	$36.09 - $53.79 $264,756 - $394,603	7,336 Added 42.11%	24,759 $1.02 Million
Q3 2021 Nov 15, 2021	BUY	$35.62 - $52.97 $77,331 - $114,997	2,171 Added 14.23%	17,423 $809,000
Q2 2021 Aug 13, 2021	BUY	$32.94 - $56.62 $76,947 - $132,264	2,336 Added 18.09%	15,252 $610,000
Q1 2021 May 14, 2021	SELL	$44.47 - $81.38 $56,877 - $104,085	-1,279 Reduced 9.01%	12,916 $694,000
Q4 2020 Feb 12, 2021	SELL	$32.49 - $61.88 $779 - $1,485	-24 Reduced 0.17%	14,195 $694,000
Q3 2020 Nov 16, 2020	BUY	$26.73 - $35.67 $11,253 - $15,017	421 Added 3.05%	14,219 $462,000
Q2 2020 Aug 14, 2020	SELL	$19.49 - $28.11 $15,202 - $21,925	-780 Reduced 5.35%	13,798 $358,000
Q1 2020 May 14, 2020	BUY	$16.13 - $30.17 $20,436 - $38,225	1,267 Added 9.52%	14,578 $354,000
Q4 2019 Feb 13, 2020	SELL	$20.78 - $29.99 $1,226 - $1,769	-59 Reduced 0.44%	13,311 $369,000
Q3 2019 Nov 13, 2019	SELL	$23.87 - $30.93 $1,599 - $2,072	-67 Reduced 0.5%	13,370 $320,000
Q2 2019 Aug 14, 2019	BUY	$22.1 - $28.56 $296,957 - $383,760	13,437 New	13,437 $383,000

Others Institutions Holding VCYT

# of Institutions

254

Shares Held

82.1M

Call Options Held

42.3K

Put Options Held

18.2K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.42B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Veracyte, Inc. Transaction History